UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Vaccine, 2022-03, Vol.40 (10), p.1499-1511

2022

Volltextzugriff (PDF)

International Consensus (ICON): allergic reactions to vaccines

The World Allergy Organization journal, 2016-09, Vol.9 (1), p.32-32, Article 32

2016

Volltextzugriff (PDF)

Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated

Vaccine, 2017-06, Vol.35 (26), p.3416-3422

2017

Volltextzugriff (PDF)

An algorithm for treatment of patients with hypersensitivity reactions after vaccines

Pediatrics (Evanston), 2008-09, Vol.122 (3), p.e771-e777

2008

Volltextzugriff (PDF)

Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009–2010 season in the active component U.S. military and civilians aged 17–44 years reported to the Vaccine Adverse Event Reporting System

Vaccine, 2016-08, Vol.34 (37), p.4406-4414

2016

Volltextzugriff (PDF)

Ischemic cardiac events and other adverse events following ACAM2000® smallpox vaccine in the Vaccine Adverse Event Reporting System

Vaccine, 2014-08, Vol.32 (37), p.4758-4765

2014

Volltextzugriff (PDF)

MULTIDISCIPLINARY CARDIOVASCULAR TEAM REVIEW CAPTURES PRECLINICAL DISEASE

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.2103-2103

2017

Volltextzugriff (PDF)

Personalized Medicine and Understanding Needle Fear: Number of Childhood Vaccines Recommended at Year of Birth Correlates with Increased Childhood and Adult Needle Fear

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB147-AB147

2017

Volltextzugriff (PDF)

Humoral responses to independent vaccinations are correlated in healthy boosted adults

Vaccine, 2014-09, Vol.32 (43), p.5624-5631

2014

Volltextzugriff (PDF)

Anthrax vaccination induced anti-lethal factor IgG: Fine specificity and neutralizing capacity

Vaccine, 2011-05, Vol.29 (20), p.3670-3678

2011

Volltextzugriff (PDF)

Complementary and alternative medicine for the allergist-immunologist: Where do I start?

Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.309-316.e4

2009

Volltextzugriff (PDF)

Complementary and alternative medicine education: Need for expanded educational resources for American Academy of Allergy, Asthma & Immunology members

Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.511-512

2009

Volltextzugriff (PDF)

Host immune responses to influenza infection and vaccines

Annals of allergy, asthma, & immunology, 2020-07, Vol.125 (1), p.2-3

2020

Volltextzugriff (PDF)

Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges

Annals of allergy, asthma, & immunology, 2020-07, Vol.125 (1), p.2-3

2020

Volltextzugriff (PDF)

Mosquito bite pathogenesis in necrotic skin reactors

Current opinion in allergy and clinical immunology, 2001-08, Vol.1 (4), p.349-352

Engler, R J

2001

Volltextzugriff (PDF)

Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients

Clinical and vaccine immunology, 2017-11, Vol.24 (11)

2017

Volltextzugriff (PDF)

Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification

Obesity (Silver Spring, Md.), 2015-06, Vol.23 (6), p.1312-1319

2015

Volltextzugriff (PDF)

Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009–2010 season in the active component U.S. military and civilians aged 17–44years reported to the Vaccine Adverse Event Reporting System

Vaccine, 2016-08, Vol.34 (37), p.4406-4414

2016

Volltextzugriff (PDF)

Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network

Pediatrics (Evanston), 2011-05, Vol.127 Suppl 1 (Supplement_1), p.S65-S73

2011

Volltextzugriff (PDF)

Select Human Anthrax Protective Antigen Epitope-Specific Antibodies Provide Protection from Lethal Toxin Challenge

The Journal of infectious diseases, 2010-07, Vol.202 (2), p.251-260

2010

Volltextzugriff (PDF)

Lethal Factor Antibodies Contribute to Lethal Toxin Neutralization in Recipients of Anthrax Vaccine Precipitated1

Vaccine, 2017-05, Vol.35 (26), p.3416-3422

2017

Volltextzugriff (PDF)

Smallpox vaccination: Risk considerations for patients with atopic dermatitis

Journal of allergy and clinical immunology, 2002-09, Vol.110 (3), p.357-365

2002

Volltextzugriff (PDF)

Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination

Clinical and vaccine immunology, 2016-08, Vol.23 (8), p.664-671

2016

Volltextzugriff (PDF)

Insufficient Anthrax Lethal Toxin Neutralization Is Associated with Antibody Subclass and Domain Specificity in the Plasma of Anthrax-Vaccinated Individuals

Microorganisms (Basel), 2021-06, Vol.9 (6), p.1204

2021

Volltextzugriff (PDF)

Myopericarditis following Smallpox Vaccination

American journal of epidemiology, 2004-10, Vol.160 (7), p.642-651

2004

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

International Consensus (ICON): allergic reactions to vaccines

Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated

An algorithm for treatment of patients with hypersensitivity reactions after vaccines

Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009–2010 season in the active component U.S. military and civilians aged 17–44 years reported to the Vaccine Adverse Event Reporting System

Ischemic cardiac events and other adverse events following ACAM2000® smallpox vaccine in the Vaccine Adverse Event Reporting System

MULTIDISCIPLINARY CARDIOVASCULAR TEAM REVIEW CAPTURES PRECLINICAL DISEASE

Personalized Medicine and Understanding Needle Fear: Number of Childhood Vaccines Recommended at Year of Birth Correlates with Increased Childhood and Adult Needle Fear

Humoral responses to independent vaccinations are correlated in healthy boosted adults

Anthrax vaccination induced anti-lethal factor IgG: Fine specificity and neutralizing capacity

Complementary and alternative medicine for the allergist-immunologist: Where do I start?

Complementary and alternative medicine education: Need for expanded educational resources for American Academy of Allergy, Asthma & Immunology members

Host immune responses to influenza infection and vaccines

Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges

Mosquito bite pathogenesis in necrotic skin reactors

Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients

Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification

Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009–2010 season in the active component U.S. military and civilians aged 17–44years reported to the Vaccine Adverse Event Reporting System

Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network

Select Human Anthrax Protective Antigen Epitope-Specific Antibodies Provide Protection from Lethal Toxin Challenge

Lethal Factor Antibodies Contribute to Lethal Toxin Neutralization in Recipients of Anthrax Vaccine Precipitated1

Smallpox vaccination: Risk considerations for patients with atopic dermatitis

Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination

Insufficient Anthrax Lethal Toxin Neutralization Is Associated with Antibody Subclass and Domain Specificity in the Plasma of Anthrax-Vaccinated Individuals

Myopericarditis following Smallpox Vaccination

Aktive Filter

Suchergebnisse filtern